These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34401710)

  • 1. Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules.
    Maszota-Zieleniak M; Samsonov SA
    Methods Mol Biol; 2024; 2714():143-153. PubMed ID: 37676597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational insights into heparin-small molecule interactions: Evaluation of the balance between stacking and non-stacking binding modes.
    Maszota-Zieleniak M; Zsila F; Samsonov SA
    Carbohydr Res; 2021 Sep; 507():108390. PubMed ID: 34271478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repulsive Scaling Replica Exchange Molecular Dynamics in Modeling Protein-Glycosaminoglycan Complexes.
    Marcisz M; Maszota-Zieleniak M; Samsonov SA
    Methods Mol Biol; 2023; 2619():153-167. PubMed ID: 36662469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico approaches for better understanding cysteine cathepsin-glycosaminoglycan interactions.
    Bojarski KK; David A; Lecaille F; Samsonov SA
    Carbohydr Res; 2024 Jul; 543():109201. PubMed ID: 39013335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective on computational simulations of glycosaminoglycans.
    Nagarajan B; Sankaranarayanan NV; Desai UR
    Wiley Interdiscip Rev Comput Mol Sci; 2019; 9(2):. PubMed ID: 31080520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations to understand glycosaminoglycan interactions in the free- and protein-bound states.
    Nagarajan B; Holmes SG; Sankaranarayanan NV; Desai UR
    Curr Opin Struct Biol; 2022 Jun; 74():102356. PubMed ID: 35306321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance.
    Quittot N; Sebastiao M; Bourgault S
    Biochem Cell Biol; 2017 Jun; 95(3):329-337. PubMed ID: 28177755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic degradation of glycosaminoglycans.
    Ernst S; Langer R; Cooney CL; Sasisekharan R
    Crit Rev Biochem Mol Biol; 1995; 30(5):387-444. PubMed ID: 8575190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of glycosaminoglycans in serum amyloid A fibril formation by
    Maszota-Zieleniak M; Danielsson A; Samsonov SA
    Matrix Biol Plus; 2021 Dec; 12():100080. PubMed ID: 34401710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
    Aguilera JJ; Zhang F; Beaudet JM; Linhardt RJ; Colón W
    Biochimie; 2014 Sep; 104():70-80. PubMed ID: 24878279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
    Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
    Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long Glycosaminoglycans.
    Marcisz M; Maszota-Zieleniak M; Huard B; Samsonov SA
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Different Glycosaminoglycans on the Structure and Aggregation of the Amyloid-β (16-22) Peptide.
    Samantray S; Strodel B
    J Phys Chem B; 2021 Jun; 125(21):5511-5525. PubMed ID: 34027669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of replica exchange with repulsive scaling approach for docking glycosaminoglycans.
    Maszota-Zieleniak M; Marcisz M; Kogut MM; Siebenmorgen T; Zacharias M; Samsonov SA
    J Comput Chem; 2021 Jun; 42(15):1040-1053. PubMed ID: 33768554
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.